Adastra Labs

B2B Cannabis and Hemp Extraction Services

Overview

Adastra Labs Holdings Ltd. is in the process of becoming a standard cannabis processor and analytical testing laboratory in Canada. The company has applied for its standard processing license which it expects to receive in the near term and its subsidiary Chemia Analytics has received an analytical testing license from Health Canada. When the company obtains its standard processing license, Adastra Labs intends to become a one-stop-shop for cannabis concentrates and value-added cannabis products.

With the cannabis extracts market expected to reach $2.1 billion by 2020, CBD extracts are part of the fastest-growing segment in the Canadian cannabis market. This is further compounded by Health Canada, who has announced that new cannabis products will be legally available in Canada by mid-December. These products include vaporizers, edibles, beverages and topicals.

Adastra Labs owns a 13,000-square-foot former food packaging facility in Langley, British Columbia. The company is currently retrofitting the building which has been designed with good manufacturing practices (GMP) compliance in mind. The facility is expected to produce significant amounts of cannabis and hemp oil for the Canadian wholesale medical and recreational markets.

Adastra Labs’ Company Highlights

  • Adastra Labs aims to be a leading standard cannabis processor.
  • The company’s B2B strategy bridges the gap between cannabis cultivators and extraction.
  • Adastra Labs plans to be a one-stop-shop for cannabis concentrates.
  • The company owns a 13,000-square-foot facility in Langley, British Columbia that is being retrofitted to GMP standards.